Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a Specialist24HrDoc, Inc. was cited for offering compounded semaglutide and tirzepatide products with false or misleading claims and labeling in violation of the Federal Food, Drug, and Cosmetic Act. The company falsely represented itself as the compounder of these drugs and made claims that the products had "same ingredients" as FDA-approved drugs like Ozempic, Wegovy, Mounjaro, and Zepbound, implying FDA approval or evaluation when the compounded products had neither. These misbranded drugs were offered for sale through the company's website and introduced into interstate commerce without proper authorization.